Error loading player: No playable sources found
4515
Dietary and Microbial Derived Bioactive Compounds: Impact on Gastrointestinal Mucosal Health
Date
May 20, 2024
Related Products
Gut Microbiome — Ally or Foe for Immune Checkpoint Inhibitors
SOCIETY: AGA This session will explore the complex dynamics between the gut microbiome and immune checkpoint inhibitors, addressing whether specific microbes/metabolites enhance therapeutic outcomes acting as allies or present challenges as potential foes, impacting treatment efficacy and associate…
AGA Diet-Driven Gut Microbiome Dynamics, Metabolism and Extinction
This session showcases the pioneering work done by the MMT section mentor awardee Dr. Justin Sonnenburg and his mentees who are leading independent programs focused on the intersection of diet-microbe-host physiology…
Tiny Ecosystems, Big Impact: Unlocking the Secrets of the Early Life Microbiome
SOCIETY: AGA This session is focused on the early life microbiome and its importance for immune maturation that affects both childhood diseases as well as future development of allergic and autoimmune diseases…
Microbiome Therapeutics: Charting the Path to Clinical Success
SOCIETY: AGA The session will highlight the current state of microbiome therapeutics, the challenges with developing and testing them in humans and the outlook for future of microbiome therapies beyond FMT…